![Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone](https://journals.sagepub.com/cms/10.1177/2050640617736478/asset/images/large/10.1177_2050640617736478-fig1.jpeg)
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial - Cesare Cremon, Simone
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://pub.mdpi-res.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g004.png?1648626041)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration](https://www.frontiersin.org/files/Articles/150035/fmicb-06-00952-HTML/image_m/fmicb-06-00952-g005.jpg)
Frontiers | The vaginal isolate Lactobacillus paracasei LPC-S01 (DSM 26760) is suitable for oral administration
The Lactobacillus Casei Group: Exploitation for Food and Health-Related Applications | Frontiers Research Topic
![Microorganisms | Free Full-Text | Expression of DinJ-YafQ System of Lactobacillus casei Group Strains in Response to Food Processing Stresses Microorganisms | Free Full-Text | Expression of DinJ-YafQ System of Lactobacillus casei Group Strains in Response to Food Processing Stresses](https://pub.mdpi-res.com/microorganisms/microorganisms-07-00438/article_deploy/html/images/microorganisms-07-00438-g001.png?1572499960)
Microorganisms | Free Full-Text | Expression of DinJ-YafQ System of Lactobacillus casei Group Strains in Response to Food Processing Stresses
![Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice | Annals of Microbiology | Full Text Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice | Annals of Microbiology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13213-021-01655-3/MediaObjects/13213_2021_1655_Fig2_HTML.png)
Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice | Annals of Microbiology | Full Text
![PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population](https://i1.rgstatic.net/publication/329278496_Survival_of_L_casei_DGR_Lactobacillus_paracasei_CNCMI1572_in_the_gastrointestinal_tract_of_a_healthy_paediatric_population/links/5fb7ca1092851c933f432f48/largepreview.png)
PDF) Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population
![PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study](https://www.researchgate.net/publication/348446334/figure/fig1/AS:979756568829953@1610603577406/Study-schedule-and-CONSORT-flow-diagram_Q320.jpg)
PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
![Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial | European Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial | European](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fejcn.2010.65/MediaObjects/41430_2010_Article_BFejcn201065_Fig1_HTML.jpg)
Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial | European
![(PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome (PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome](https://i1.rgstatic.net/publication/316113280_Lactobacillus_casei_DG_and_its_postbiotic_reduce_the_inflammatory_mucosal_response_An_ex-vivo_organ_culture_model_of_post-infectious_irritable_bowel_syndrome/links/5fc24c58299bf104cf889f4a/largepreview.png)
(PDF) Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-t001.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![PDF) Probiotic Crescenza Cheese Containing Lactobacillus casei and Lactobacillus acidophilus Manufactured with High-Pressure Homogenized Milk | Francesca Patrignani - Academia.edu PDF) Probiotic Crescenza Cheese Containing Lactobacillus casei and Lactobacillus acidophilus Manufactured with High-Pressure Homogenized Milk | Francesca Patrignani - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47650007/mini_magick20190206-19127-n772ww.png?1549455123)
PDF) Probiotic Crescenza Cheese Containing Lactobacillus casei and Lactobacillus acidophilus Manufactured with High-Pressure Homogenized Milk | Francesca Patrignani - Academia.edu
![So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care](https://m.media-amazon.com/images/I/61wVH0S2udL._AC_UF894,1000_QL80_.jpg)
So Far Nahrungsergänzungsmittel Enterolactis Baby Tropfen, 8 ml, 8 ml, 1 : Amazon.de: Health & Personal Care
![PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study](https://i1.rgstatic.net/publication/348446334_The_use_of_Lactobacillus_casei_DGR_prevents_symptomatic_episodes_and_reduces_the_antibiotic_use_in_patients_affected_by_chronic_bacterial_prostatitis_results_from_a_phase_IV_study/links/5fffdc3992851c13fe0d7e21/largepreview.png)
PDF) The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
![Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-010-1384-1/MediaObjects/10620_2010_1384_Fig2_HTML.gif)
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences
![PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics](https://i1.rgstatic.net/publication/234124642_Comparative_Genomic_and_Functional_Analysis_of_Lactobacillus_casei_and_Lactobacillus_rhamnosus_Strains_Marketed_as_Probiotics/links/548fd6f20cf225bf66a80558/largepreview.png)
PDF) Comparative Genomic and Functional Analysis of Lactobacillus casei and Lactobacillus rhamnosus Strains Marketed as Probiotics
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g002.jpg)
Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults
![Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species](https://pub.mdpi-res.com/microorganisms/microorganisms-10-01023/article_deploy/html/images/microorganisms-10-01023-g001a.png?1652421089)
Microorganisms | Free Full-Text | Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species
![JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease](https://www.mdpi.com/jcm/jcm-11-01916/article_deploy/html/images/jcm-11-01916-g001.png)
JCM | Free Full-Text | Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig4_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains](https://pub.mdpi-res.com/foods/foods-10-02239/article_deploy/html/images/foods-10-02239-g001.png?1632272477)
Foods | Free Full-Text | Health-Promoting Properties of Lacticaseibacillus paracasei: A Focus on Kefir Isolates and Exopolysaccharide-Producing Strains
![The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00345-020-03580-7/MediaObjects/345_2020_3580_Fig1_HTML.png)
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study | World Journal of Urology
![Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-75930-9/MediaObjects/41598_2020_75930_Fig2_HTML.png)
Lactobacillus casei extracellular vesicles stimulate EGFR pathway likely due to the presence of proteins P40 and P75 bound to their surface | Scientific Reports
![Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00394-018-1860-5/MediaObjects/394_2018_1860_Fig1_HTML.png)
Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig2_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-017-0605-x/MediaObjects/12876_2017_605_Fig3_HTML.gif)
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome | BMC Gastroenterology | Full Text
![Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10620-010-1384-1/MediaObjects/10620_2010_1384_Fig3_HTML.gif)
Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis | Digestive Diseases and Sciences
SOFAR - ENTEROLACTIS® is the best ally to promote the balance of intestinal flora. The products in the range are mainly formulated with L. casei DG®, an exclusive probiotic strain, created and
![Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00394-018-1860-5/MediaObjects/394_2018_1860_Fig2_HTML.png)
Survival of L. casei DG® (Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population | European Journal of Nutrition
![A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology](https://journals.asm.org/cms/10.1128/AEM.02702-16/asset/8c3ea820-dcae-481d-98d7-c97a81614bda/assets/graphic/zam9991176330001.jpeg)
A Novel Rhamnose-Rich Hetero-exopolysaccharide Isolated from Lactobacillus paracasei DG Activates THP-1 Human Monocytic Cells | Applied and Environmental Microbiology
![Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults Frontiers | Quantitative Recovery of Viable Lactobacillus paracasei CNCM I-1572 (L. casei DG®) After Gastrointestinal Passage in Healthy Adults](https://www.frontiersin.org/files/Articles/372902/fmicb-09-01720-HTML/image_m/fmicb-09-01720-g003.jpg)